O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.71B
AUM Growth
+$1.28B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$249M
2
+$119M
3
+$107M
4
XLRN
Acceleron Pharma
XLRN
+$83.9M
5
CELG
Celgene Corp
CELG
+$76.1M

Top Sells

1
+$177M
2
+$71.8M
3
+$56.2M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$56.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.4M

Sector Composition

1 Healthcare 84.81%
2 Financials 1.2%
3 Technology 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$10M 0.15%
1,637,500
-246,700
77
$9.12M 0.13%
+279,000
78
$9.06M 0.13%
143,000
+13,000
79
$8.41M 0.12%
130,000
80
$8.35M 0.12%
1
81
$8.34M 0.12%
139,000
+19,000
82
$6.99M 0.1%
447,500
83
$6.42M 0.09%
+702,600
84
$6.22M 0.09%
+55,000
85
$6.2M 0.09%
90,000
-814,200
86
$6.12M 0.09%
+700,000
87
$5.85M 0.09%
232,080
88
$5.5M 0.08%
19,501
89
$5.2M 0.08%
59,000
+11,000
90
$4.73M 0.07%
200,000
-864,000
91
$4.41M 0.06%
+702,000
92
$4.37M 0.06%
580,000
-59,400
93
$4.36M 0.06%
80,000
94
$3.94M 0.06%
1,443,500
95
$3.69M 0.05%
1,895,000
96
$3.51M 0.05%
+85,000
97
$3.37M 0.05%
135,000
-177,000
98
$3.19M 0.05%
1,892
-333
99
$2.86M 0.04%
116,594
100
$2.51M 0.04%
450,000
-150,000
2 3
4
5 6